Tasly Pharmaceuticals and Mauna Kea Technologies Announce Joint Venture and Licensing Agreements
Mauna Kea to form Joint Venture (JV) with Tasly to develop, manufacture and commercialize Cellvizio…
4 years ago
Wire Stories
Tamil Nadu government and TaskUs sign MoU for new Chennai Technology Center of Excellence
CHENNAI, India--(BUSINESS WIRE)--TaskUs (Nasdaq: TASK), a provider of outsourced digital services and next-generation customer experience…
4 years ago
SharpLink Gaming CEO Rob Phythian Invited to Speak at SBC Summit North America 2022 This Week at the Meadowlands
MINNEAPOLIS, July 11, 2022 (GLOBE NEWSWIRE) -- SharpLink Gaming Ltd. (Nasdaq:SBET) (“SharpLink” or the “Company”),…
4 years ago
Edgecore Networks Assembles the OpenWiFi Expert Team – Oxherd – to Assist Clients with OpenWiFi Issues
The Oxherd team puts you at ease at every stage of OpenWiFi HSINCHU, Taiwan--(BUSINESS WIRE)--Edgecore…
4 years ago
Wisk Brings 5th Generation Aircraft to the UK and Australia with Two Public Displays
Two of Wisk’s Fleet of Aircraft will be on Display as part of the Company’s…
4 years ago
Australia’s Largest Footwear Company Runs With Boomi To Hasten E-commerce and Transformation Roadmap
Munro Footwear Group connects digital dots to create a central nervous system for online offering…
4 years ago
Twenty20 Energy to Build First-of-its-Kind “Power Island” FSRP in Papua New Guinea
Power Island Floating Storage Regasification & Power Solution Features Proprietary Design to Provide 283MW Capacity…
4 years ago
Monarch Partners with Einsite, an India-based AI Startup, to Accelerate Farm Autonomy
LIVERMORE, Calif.--(BUSINESS WIRE)--#agriculture--Monarch Tractor, maker of the first fully electric, driver-optional, smart tractor, today announced…
4 years ago
The Official Side Event of UN Ocean Conference 2022 — “Blue Partnership Action Fund” Officially Launched
BEIJING--(BUSINESS WIRE)--The official side event, “Promoting Blue Partnership for a Shared Sustainable Future”, was held…
4 years ago
Overland ADCT BioPharma Announces First Patient Dosed in China with ZYNLONTA® in Combination with Rituximab in Global Phase 3 Clinical Trial
LOTIS-5 is intended to serve as the basis for a supplemental BLA (sBLA) in the…
4 years ago